Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Botulinum Toxin Type A for overactive bladder is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Lanzhou Institute of Biological Products Co., Ltd | Conditions: Overactive Bladder | Phase 3 | Status: UNKNOWN